PureTech Health plc (PRTC)
USD 17.25
(-9.5%)
USD 17.25
(-9.5%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -167.19 Million USD | -62.34% |
| 2022 | -102.99 Million USD | 75.1% |
| 2021 | -413.68 Million USD | -26.41% |
| 2020 | -327.25 Million USD | -251.66% |
| 2019 | -93.06 Million USD | 11.1% |
| 2018 | -104.68 Million USD | -60.57% |
| 2017 | -65.19 Million USD | -16.41% |
| 2016 | -56 Million USD | 56.85% |
| 2015 | -129.79 Million USD | 38.78% |
| 2014 | -212.01 Million USD | -7180.63% |
| 2013 | -2.91 Million USD | 69.01% |
| 2012 | -9.39 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -183.74 Million USD | -9.89% |
| 2024 Q2 | -183.74 Million USD | 10.88% |
| 2023 FY | -167.19 Million USD | -62.34% |
| 2023 Q3 | -58.97 Million USD | 81.85% |
| 2023 Q1 | -224.43 Million USD | -117.91% |
| 2023 Q4 | -167.19 Million USD | -183.51% |
| 2023 Q2 | -324.93 Million USD | -44.78% |
| 2022 FY | -102.99 Million USD | 75.1% |
| 2022 Q3 | -107.96 Million USD | 66.03% |
| 2022 Q4 | -102.99 Million USD | 4.61% |
| 2022 Q1 | -322.44 Million USD | 22.05% |
| 2022 Q2 | -317.81 Million USD | 1.44% |
| 2021 Q2 | -362.17 Million USD | 0.95% |
| 2021 FY | -413.68 Million USD | -26.41% |
| 2021 Q4 | -413.68 Million USD | 0.77% |
| 2021 Q3 | -416.9 Million USD | -15.11% |
| 2021 Q1 | -365.63 Million USD | -11.73% |
| 2020 FY | -327.25 Million USD | -251.66% |
| 2020 Q3 | -330.52 Million USD | -9.57% |
| 2020 Q2 | -301.66 Million USD | 1.01% |
| 2020 Q4 | -327.25 Million USD | 0.99% |
| 2020 Q1 | -304.73 Million USD | -227.45% |
| 2019 Q1 | -68.54 Million USD | 34.52% |
| 2019 Q3 | -95.99 Million USD | -42.42% |
| 2019 Q4 | -93.06 Million USD | 3.05% |
| 2019 FY | -93.06 Million USD | 11.1% |
| 2019 Q2 | -67.39 Million USD | 1.67% |
| 2018 Q3 | -105.04 Million USD | -35.3% |
| 2018 FY | -104.68 Million USD | -60.57% |
| 2018 Q4 | -104.68 Million USD | 0.34% |
| 2018 Q2 | -77.63 Million USD | 0.0% |
| 2018 Q1 | -77.63 Million USD | -19.09% |
| 2017 Q3 | -65.19 Million USD | -3.46% |
| 2017 Q1 | -63.01 Million USD | -14.34% |
| 2017 Q2 | -63.01 Million USD | 0.0% |
| 2017 FY | -65.19 Million USD | -16.41% |
| 2017 Q4 | -65.19 Million USD | 0.0% |
| 2016 Q2 | -66.1 Million USD | 0.0% |
| 2016 Q4 | -55.1 Million USD | 1.6% |
| 2016 FY | -56 Million USD | 56.85% |
| 2016 Q3 | -56 Million USD | 15.28% |
| 2016 Q1 | -66.1 Million USD | 49.07% |
| 2015 Q1 | -217.97 Million USD | -2.81% |
| 2015 Q3 | -129.79 Million USD | 40.45% |
| 2015 FY | -129.79 Million USD | 38.78% |
| 2015 Q4 | -129.79 Million USD | 0.0% |
| 2015 Q2 | -217.97 Million USD | 0.0% |
| 2014 Q3 | -55.01 Million USD | 0.0% |
| 2014 Q1 | 8.88 Million USD | 0.0% |
| 2014 Q4 | -212.01 Million USD | -285.39% |
| 2014 FY | -212.01 Million USD | -7180.63% |
| 2013 FY | -2.91 Million USD | 69.01% |
| 2012 FY | -9.39 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -198.886% |
| Alkermes plc | -166.73 Million USD | -0.275% |
| Agenus Inc. | 274.13 Million USD | 160.991% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 108.941% |
| Aptorum Group Limited | 1.35 Million USD | 12420.658% |
| Ardelyx, Inc. | 34.51 Million USD | 584.46% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4006.472% |
| Bicycle Therapeutics plc | -481.46 Million USD | 65.273% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 562.343% |
| ChromaDex Corporation | -24.04 Million USD | -595.264% |
| Chimerix, Inc. | -25.51 Million USD | -555.238% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2499.472% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -606.158% |
| CRISPR Therapeutics AG | -150.84 Million USD | -10.84% |
| Precision BioSciences, Inc. | -85.41 Million USD | -95.758% |
| Dyadic International, Inc. | -6.37 Million USD | -2521.424% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -949.376% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2281.305% |
| Lantern Pharma Inc. | -21.7 Million USD | -670.377% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -51.259% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1857.082% |
| Incyte Corporation | -3.17 Billion USD | 94.734% |
| IO Biotech, Inc. | -140.69 Million USD | -18.833% |
| Jaguar Health, Inc. | 29.39 Million USD | 668.871% |
| Novavax, Inc. | -298.29 Million USD | 43.949% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3232.79% |
| Opthea Limited | 28.15 Million USD | 693.793% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -895.872% |
| ContextLogic Inc. | -232 Million USD | 27.932% |
| MiMedx Group, Inc. | -33.9 Million USD | -393.192% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1739.99% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7116.014% |
| NextCure, Inc. | -6.47 Million USD | -2481.396% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -231.077% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2521.053% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1474.606% |
| Vaxcyte, Inc. | -368.22 Million USD | 54.594% |
| PDS Biotechnology Corporation | -32.7 Million USD | -411.167% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1067.687% |
| Pharming Group N.V. | 109.8 Million USD | 252.269% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -861.123% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 4.584% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -802.799% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -802.799% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2254.887% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2753.191% |
| Acelyrin, Inc. | -216.9 Million USD | 22.916% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2880.197% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -9598.202% |
| Summit Therapeutics Inc. | 34.67 Million USD | 582.197% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2357.695% |
| Senti Biosciences, Inc. | 1.74 Million USD | 9709.023% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 9.431% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -115.875% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2658.116% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 167684.119% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 26723.726% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -42.847% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 0.616% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 250.805% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2101.119% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -29.496% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2525.043% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 31.014% |
| Immix Biopharma, Inc. | -17.5 Million USD | -854.877% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 47.207% |
| MEI Pharma, Inc. | -3.7 Million USD | -4412.74% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1436.4% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 203.373% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 701.58% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2281.305% |
| Precigen, Inc. | -481 Thousand USD | -34660.291% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1287.394% |
| AlloVir, Inc. | -62.69 Million USD | -166.696% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -200.638% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 371.133% |
| ImmuCell Corporation | 10.99 Million USD | 1621.278% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -8.467% |
| Onconetix, Inc. | 5.33 Million USD | 3236.059% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -448.907% |
| Elevation Oncology, Inc. | -19.11 Million USD | -774.553% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3305.928% |
| Seer, Inc. | -4.24 Million USD | -3843.325% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -595.582% |
| Innoviva, Inc. | 255.56 Million USD | 165.423% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -199.293% |
| ESSA Pharma Inc. | -33.62 Million USD | -397.291% |
| GlycoMimetics, Inc. | -40.98 Million USD | -307.953% |
| GT Biopharma, Inc. | -1.02 Million USD | -16275.808% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -146.665% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 372.944% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -24.7% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1106.676% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -479.097% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -221840.956% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -441.757% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1940.267% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5243.434% |
| Soligenix, Inc. | -4.95 Million USD | -3276.628% |
| Century Therapeutics, Inc. | 847 Thousand USD | 19839.906% |
| Kura Oncology, Inc. | -20.11 Million USD | -731.082% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -308.535% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1890.915% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9278.101% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5129.809% |
| Autolus Therapeutics plc | -186.59 Million USD | 10.398% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -239.114% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 39.376% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 587.91% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 201.721% |
| GRI Bio, Inc. | -1.79 Million USD | -9219.788% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1761.251% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -402.742% |
| IGM Biosciences, Inc. | -72.6 Million USD | -130.28% |
| INmune Bio, Inc. | -25.41 Million USD | -557.971% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 210.762% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -230.044% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -928.944% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5695.539% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 539.818% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -305.966% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 624.375% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 144.238% |
| Verastem, Inc. | -37.27 Million USD | -348.514% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1742.797% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -222.388% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1004.704% |
| Histogen Inc. | -7.48 Million USD | -2133.164% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -673.816% |
| Surrozen, Inc. | -32.66 Million USD | -411.869% |
| Organovo Holdings, Inc. | -1.5 Million USD | -10994.691% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3877.578% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 981.831% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6491.323% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4123.027% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1894.917% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -284.874% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1047.003% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 47.221% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -23055.555% |
| Apollomics, Inc. | -27.39 Million USD | -510.319% |
| Amarin Corporation plc | -191.04 Million USD | 12.481% |
| Mesoblast Limited | 55.96 Million USD | 398.763% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1046.441% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -561.067% |
| Synaptogenix, Inc. | -28.66 Million USD | -483.351% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -17762.927% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 443.095% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19294.401% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2201.062% |
| Exelixis, Inc. | -73.05 Million USD | -128.88% |
| Better Therapeutics, Inc. | -860 Thousand USD | -19341.512% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -596.277% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 30.73% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 22814.947% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2147.835% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 13433.094% |
| Gritstone bio, Inc. | 39.49 Million USD | 523.391% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -98.805% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6252.132% |
| Avid Bioservices, Inc. | 169.72 Million USD | 198.509% |
| Insmed Incorporated | 721.62 Million USD | 123.17% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1728.986% |
| MediWound Ltd. | -5.32 Million USD | -3041.62% |
| OmniAb, Inc. | 9.2 Million USD | 1916.766% |
| Alector, Inc. | -35.63 Million USD | -369.167% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 294.481% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3292.796% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1362.913% |
| Zai Lab Limited | -775 Million USD | 78.426% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 149.095% |
| Aura Biosciences, Inc. | -21.52 Million USD | -676.757% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -102.712% |
| Immunic, Inc. | -45.34 Million USD | -268.763% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 13.466% |
| Veracyte, Inc. | -203.82 Million USD | 17.97% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 126.194% |
| FibroGen, Inc. | 56.76 Million USD | 394.532% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1977.563% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5814.119% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -7975.792% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.642% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -4904.4% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -0.743% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1036.049% |
| Galecto, Inc. | -21.21 Million USD | -688.07% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -602.951% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 110.654% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -583.218% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1353.003% |
| XBiotech Inc. | -200.02 Million USD | 16.411% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -98.805% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3792.513% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -374.143% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -116.526% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3037.92% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 1.888% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -81.0% |
| Vaxxinity, Inc. | 10.13 Million USD | 1750.188% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 122.709% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1452.786% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -153.498% |
| NexImmune, Inc. | -3.13 Million USD | -5235.547% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4742.538% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1006.426% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -516.963% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1762.701% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -134113.927% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -312.099% |
| Ainos, Inc. | 4.07 Million USD | 4200.048% |
| Pluri Inc. | 22.82 Million USD | 832.389% |
| Prothena Corporation plc | -608.34 Million USD | 72.516% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -40.79% |
| Celularity Inc. | 65.19 Million USD | 356.476% |
| Rallybio Corporation | -24.1 Million USD | -593.706% |
| Cue Biopharma, Inc. | -33.81 Million USD | -394.388% |
| MeiraGTx Holdings plc | -40.3 Million USD | -314.86% |
| Omeros Corporation | 331.17 Million USD | 150.486% |
| Humacyte, Inc. | -22.48 Million USD | -643.56% |
| Immunocore Holdings plc | -358.59 Million USD | 53.374% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -580.354% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -441.073% |
| Blueprint Medicines Corporation | 702.83 Million USD | 123.789% |
| CalciMedica, Inc. | -5.53 Million USD | -2923.454% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 11.169% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1536.939% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -317.606% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -402.803% |
| Pulmatrix, Inc. | -10.41 Million USD | -1505.04% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2697.34% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -338.354% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -50.084% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -178.922% |
| Cytokinetics, Incorporated | 642.37 Million USD | 126.028% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2771.321% |
| Nutriband Inc. | -251.65 Thousand USD | -66338.446% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -390.041% |
| Vor Biopharma Inc. | 4.3 Million USD | 3988.302% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.23% |
| Evogene Ltd. | -19.63 Million USD | -751.569% |
| ProKidney Corp. | -56.23 Million USD | -197.313% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -243.518% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1710.042% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.259% |
| CorMedix Inc. | -43.05 Million USD | -288.356% |
| BioLineRx Ltd. | 7.33 Million USD | 2379.13% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -508.764% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 462.314% |
| Atai Life Sciences N.V. | -28.55 Million USD | -485.465% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7595.845% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -632.806% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1042.752% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -122.71% |
| MediciNova, Inc. | -50.78 Million USD | -229.235% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -112.165% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -743162.947% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2491.161% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 16.327% |
| Biomea Fusion, Inc. | -166.57 Million USD | -0.376% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 6.581% |
| Mereo BioPharma Group plc | -51.46 Million USD | -224.85% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -76.286% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 43.084% |
| Absci Corporation | -72.59 Million USD | -130.305% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3761.783% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 28.681% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -77.471% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -74.717% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -327.909% |
| Allakos Inc. | -24.97 Million USD | -569.457% |
| Imunon, Inc. | -4.21 Million USD | -3867.795% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1034.154% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -23.484% |
| BioAtla, Inc. | -109.01 Million USD | -53.376% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 22814.947% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -17705.857% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1497.267% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -688.554% |
| XOMA Corporation | -29 Million USD | -476.541% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -909.644% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1754.448% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2144.556% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -34.148% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 19.68% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -104.45% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -80.241% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -19359.976% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4248.427% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10402.423% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.108% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -13972.222% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3907.72% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 247.335% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 232440.68% |
| Orgenesis Inc. | 21.78 Million USD | 867.522% |
| Entera Bio Ltd. | -10.62 Million USD | -1473.027% |
| GH Research PLC | -78.07 Million USD | -114.144% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -650.166% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -527.169% |
| Xencor, Inc. | 29.64 Million USD | 664.016% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8387.967% |
| Replimune Group, Inc. | 1.41 Million USD | 11941.147% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -68169.309% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -32.258% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -13972.222% |
| Portage Biotech Inc. | -4.98 Million USD | -3256.695% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -743162.947% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -152.861% |
| OncoCyte Corporation | -6.56 Million USD | -2447.57% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 18730.998% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3570.108% |
| Purple Biotech Ltd. | -14.13 Million USD | -1082.607% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -603.81% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2454.576% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -901.65% |
| HilleVax, Inc. | -165.48 Million USD | -1.035% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6487.746% |
| Tharimmune, Inc. | -10.93 Million USD | -1428.959% |
| Genprex, Inc. | -6.73 Million USD | -2381.541% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 54.665% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -89.009% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -11834.118% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -4940.691% |
| OKYO Pharma Limited | -826.84 Thousand USD | -20121.008% |
| Savara Inc. | 153 Thousand USD | 109379.085% |
| Curis, Inc. | -23.88 Million USD | -599.95% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3141.564% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -21445.672% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2593.251% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14209.451% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.579% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1455.084% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 72.51% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 9.909% |
| Erasca, Inc. | -37.21 Million USD | -349.261% |
| bluebird bio, Inc. | 108.57 Million USD | 253.998% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -12882.212% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 144.145% |
| DBV Technologies S.A. | -126.98 Million USD | -31.666% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -12882.212% |
| Moderna, Inc. | -2.9 Billion USD | 94.248% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1515.118% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1438.434% |
| Molecular Templates, Inc. | 707 Thousand USD | 23748.798% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -432.967% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 148.238% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -103.745% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -82.271% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -418.087% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -386.377% |
| MacroGenics, Inc. | -66.98 Million USD | -149.604% |
| RenovoRx, Inc. | -1.17 Million USD | -14153.794% |
| Adicet Bio, Inc. | -138.78 Million USD | -20.47% |
| Prime Medicine, Inc. | -27.94 Million USD | -498.393% |
| Aditxt, Inc. | 18.12 Million USD | 1022.676% |
| Adagene Inc. | -87.62 Million USD | -90.805% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3913.921% |
| Quantum-Si incorporated | -118.55 Million USD | -41.027% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 564.372% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2136.992% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -244.672% |
| SciSparc Ltd. | -2.06 Million USD | -7996.707% |
| Vericel Corporation | 1.27 Million USD | 13192.952% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1294.273% |
| Minerva Neurosciences, Inc. | 41 Million USD | 507.755% |
| Generation Bio Co. | 31.44 Million USD | 631.662% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 4.657% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -440.688% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 243.402% |
| Invivyd, Inc. | -198.47 Million USD | 15.76% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -85.219% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -6873.258% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -136.187% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2349.773% |
| 2seventy bio, Inc. | 181.71 Million USD | 192.011% |
| ADMA Biologics, Inc. | 90.06 Million USD | 285.638% |
| Clene Inc. | 3.34 Million USD | 5105.898% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1740.829% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -677.263% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2491.161% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 51.414% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -543.073% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 194.107% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3986.381% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3442.603% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3109.772% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -28.313% |
| Evaxion Biotech A/S | 5.28 Million USD | 3262.511% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -48.53% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -27.366% |
| Trevena, Inc. | 2.25 Million USD | 7504.65% |
| Surrozen, Inc. | -32.66 Million USD | -411.869% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -224.591% |
| Cingulate Inc. | 3.08 Million USD | 5523.749% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5592.782% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2426.381% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1699.515% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -110.78% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -27.192% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -58.418% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4140.74% |
| Kronos Bio, Inc. | -36.05 Million USD | -363.741% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1876.99% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11566.559% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -208.163% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1259.769% |
| ImmunityBio, Inc. | 618.22 Million USD | 127.045% |
| Korro Bio, Inc. | -132.94 Million USD | -25.766% |
| Kineta, Inc. | -4.54 Million USD | -3581.942% |
| BioVie Inc. | -17.73 Million USD | -842.892% |
| Codexis, Inc. | -43.27 Million USD | -286.395% |
| Celularity Inc. | 65.19 Million USD | 356.476% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5176.018% |
| Celcuity Inc. | 6.78 Million USD | 2564.757% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4868.79% |
| Cibus, Inc. | -8.07 Million USD | -1969.782% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3853.582% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3758.578% |
| IN8bio, Inc. | -16.38 Million USD | -920.178% |
| Kodiak Sciences Inc. | -103.87 Million USD | -60.96% |
| Annexon, Inc. | -193.75 Million USD | 13.707% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 464536.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -855.466% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4659.379% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 115.859% |
| Eyenovia, Inc. | 1.25 Million USD | 13383.287% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 721.435% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5055.628% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -402.893% |
| Arcellx, Inc. | -296.95 Million USD | 43.697% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -757.157% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -183.986% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -706.663% |
| Moolec Science SA | 117.61 Thousand USD | 142254.979% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -335.42% |
| Geron Corporation | 14.76 Million USD | 1232.694% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -340.944% |
| Royalty Pharma plc | 5.65 Billion USD | 102.955% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -18.226% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2292.143% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3017.684% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -18.806% |
| Humacyte, Inc. | -22.48 Million USD | -643.56% |
| Structure Therapeutics Inc. | -124.33 Million USD | -34.469% |
| 89bio, Inc. | -289.05 Million USD | 42.157% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -562.376% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9277.285% |
| Genelux Corporation | -6.89 Million USD | -2323.496% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -438.321% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 299.999% |
| Notable Labs, Ltd. | -9.77 Million USD | -1610.28% |
| Liquidia Corporation | -80.17 Million USD | -108.537% |
| Mustang Bio, Inc. | -3.73 Million USD | -4375.294% |
| Immunovant, Inc. | -635.22 Million USD | 73.679% |
| Quantum-Si incorporated | -118.55 Million USD | -41.027% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -851.93% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3935.65% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2182.933% |
| Acasti Pharma Inc. | -23 Million USD | -626.785% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4865.418% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -928.944% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -21.386% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5265.134% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -652.056% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -800.409% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 1.229% |
| PepGen Inc. | -60.67 Million USD | -175.584% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -627.703% |
| United Therapeutics Corporation | -507.7 Million USD | 67.068% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -774.187% |
| Solid Biosciences Inc. | -47.75 Million USD | -250.151% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19294.401% |
| Immuneering Corporation | -54.94 Million USD | -204.311% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3877.578% |
| Silo Pharma, Inc. | -3.52 Million USD | -4644.109% |
| Belite Bio, Inc | -87.27 Million USD | -91.584% |
| XOMA Corporation | -29 Million USD | -476.541% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -136.498% |
| Bionomics Limited | 227 Million USD | 173.652% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -43.786% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6500.75% |
| uniQure N.V. | -102.95 Million USD | -62.404% |
| Cassava Sciences, Inc. | -121.13 Million USD | -38.024% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3913.921% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 508.286% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1297.851% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5303.562% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 157833.019% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5055.628% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1977.563% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2154.544% |
| Altimmune, Inc. | -134.48 Million USD | -24.322% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 184.415% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6500.75% |
| Compugen Ltd. | -12.9 Million USD | -1195.699% |
| Peak Bio, Inc. | 10.34 Million USD | 1716.968% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -58980.212% |
| Benitec Biopharma Inc. | -50.58 Million USD | -230.546% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -60.246% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 951.092% |
| Zura Bio Limited | -99.8 Million USD | -67.522% |
| PolyPid Ltd. | 6.17 Million USD | 2809.838% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 325.576% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 951.092% |
| Instil Bio, Inc. | 75.35 Million USD | 321.87% |
| argenx SE | -2.02 Billion USD | 91.759% |
| Immunome, Inc. | -97.02 Million USD | -72.317% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -643.263% |
| Verona Pharma plc | -220.44 Million USD | 24.154% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -133.05% |
| Shattuck Labs, Inc. | -121.42 Million USD | -37.697% |
| CervoMed Inc. | -7.79 Million USD | -2045.519% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 9.866% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3723.394% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -26.914% |
| Moolec Science SA | 117.61 Thousand USD | 142254.979% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7207.635% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1151.661% |
| AnaptysBio, Inc. | -18.15 Million USD | -821.145% |
| Design Therapeutics, Inc. | -18.15 Million USD | -821.196% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -137.56% |
| NeurAxis, Inc. | 145.7 Thousand USD | 114854.29% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1588.577% |
| Lumos Pharma, Inc. | -28.49 Million USD | -486.8% |
| Achilles Therapeutics plc | -126.92 Million USD | -31.73% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -133.05% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -25397.842% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -704.845% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11566.559% |
| Nutriband Inc. | -251.65 Thousand USD | -66338.446% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1169.433% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2147.272% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 149.147% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 804.432% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 62.635% |
| Palisade Bio, Inc. | -12.06 Million USD | -1286.032% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -19.162% |
| Beam Therapeutics Inc. | -262.72 Million USD | 36.36% |
| Neurogene Inc. | -131.95 Million USD | -26.708% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 866.396% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3326.168% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 55.673% |
| Sesen Bio, Inc. | -112.55 Million USD | -48.55% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -67.431% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7021.454% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -328.425% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -100.76% |
| Athira Pharma, Inc. | -88.99 Million USD | -87.864% |
| Vaccinex, Inc. | -1.28 Million USD | -12881.134% |
| HCW Biologics Inc. | 2.85 Million USD | 5952.851% |
| XOMA Corporation | -29 Million USD | -476.541% |
| Nektar Therapeutics | 210.24 Million USD | 179.527% |
| Arvinas, Inc. | -313.8 Million USD | 46.719% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10402.423% |
| Merus N.V. | -192.88 Million USD | 13.317% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 378.731% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2309.873% |
| Rezolute, Inc. | -68.16 Million USD | -145.272% |
| Clene Inc. | 3.34 Million USD | 5105.898% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1167.893% |
| BeyondSpring Inc. | -13.75 Million USD | -1115.536% |
| Synlogic, Inc. | -6.68 Million USD | -2401.077% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 14844.004% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1877.493% |
| Peak Bio, Inc. | 10.34 Million USD | 1716.968% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -102.86% |
| Krystal Biotech, Inc. | -350.23 Million USD | 52.261% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 234.701% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 1.065% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5195.831% |
| MannKind Corporation | 143.89 Million USD | 216.191% |
| Ikena Oncology, Inc. | -109.15 Million USD | -53.173% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2108.387% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -405.127% |
| Gossamer Bio, Inc. | 180.35 Million USD | 192.704% |
| CohBar, Inc. | -5.93 Million USD | -2719.163% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -462.045% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3761.783% |
| Legend Biotech Corporation | -949.39 Million USD | 82.389% |
| Mural Oncology plc | -255.84 Million USD | 34.649% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 619.004% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3449.346% |
| Disc Medicine, Inc. | -358.28 Million USD | 53.334% |
| Champions Oncology, Inc. | 4.81 Million USD | 3574.584% |
| REGENXBIO Inc. | 54.76 Million USD | 405.282% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -62076.515% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -10.709% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1755.27% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -107.227% |
| Vaxart, Inc. | -8.24 Million USD | -1928.844% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -233.195% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -31.48% |
| Cellectis S.A. | -43.85 Million USD | -281.25% |
| Longeveron Inc. | -2.9 Million USD | -5649.553% |
| Repare Therapeutics Inc. | -107.85 Million USD | -55.016% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 117.266% |
| Inozyme Pharma, Inc. | 12 Million USD | 1492.844% |
| Revolution Medicines, Inc. | -608.2 Million USD | 72.51% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -13493.252% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 36.935% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -11.411% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -968.556% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -22494.189% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.252% |
| Denali Therapeutics Inc. | -74.86 Million USD | -123.331% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1294.273% |
| Veru Inc. | 4.77 Million USD | 3597.868% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1386.724% |
| Cingulate Inc. | 3.08 Million USD | 5523.749% |
| Passage Bio, Inc. | 4.58 Million USD | 3746.609% |
| Context Therapeutics Inc. | -14.44 Million USD | -1057.087% |
| Exicure, Inc. | 5.84 Million USD | 2958.557% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 27.424% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -322.535% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1165.56% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -184.247% |
| Nuvalent, Inc. | -335.38 Million USD | 50.148% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 9740.376% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -124.48% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1780.731% |
| OmniAb, Inc. | 9.2 Million USD | 1916.766% |
| Anew Medical, Inc. | 1.43 Million USD | 11771.978% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1120.629% |
| Lipocine Inc. | -4.75 Million USD | -3416.537% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -52.235% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1197.741% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -230.044% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 771.69% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2387.68% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -153.995% |
| Ocugen, Inc. | -32.52 Million USD | -414.12% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -95.381% |
| Q32 Bio Inc. | -37.94 Million USD | -340.595% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -26523.726% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1135.842% |
| Equillium, Inc. | -22.39 Million USD | -646.682% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -553.931% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -412.453% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -67341.26% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 224.735% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5328.174% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 51006.251% |
| Dominari Holdings Inc. | 195 Thousand USD | 85842.051% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3074.48% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1775.036% |
| Bio-Techne Corporation | 267.74 Million USD | 162.446% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -931.507% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -41.58% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1889.73% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1221.611% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 31.789% |
| Nkarta, Inc. | 57.29 Million USD | 391.797% |
| BioCardia, Inc. | 212 Thousand USD | 78966.509% |
| Iterum Therapeutics plc | 13.43 Million USD | 1344.21% |